MGC Pharmaceuticals Limited
MGCLF · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $17,690 | $50,546 | $76,469 | $60,054 |
| - Cash | $240 | $1,886 | $5,433 | $1,873 |
| + Debt | $9,755 | $4,353 | $6,018 | $1,899 |
| Enterprise Value | $27,205 | $53,012 | $77,054 | $60,079 |
| Revenue | $3,388 | $4,732 | $2,996 | $2,079 |
| % Growth | -28.4% | 57.9% | 44.1% | – |
| Gross Profit | $1,286 | $1,562 | $736 | -$306 |
| % Margin | 38% | 33% | 24.6% | -14.7% |
| EBITDA | -$20,381 | -$15,160 | -$17,051 | -$18,662 |
| % Margin | -601.6% | -320.4% | -569.1% | -897.6% |
| Net Income | -$20,824 | -$20,347 | -$15,870 | -$19,363 |
| % Margin | -614.6% | -430% | -529.7% | -931.4% |
| EPS Diluted | -7.07 | -7.9 | -8.3 | -14 |
| % Growth | 10.5% | 4.8% | 40.7% | – |
| Operating Cash Flow | -$11,985 | -$12,158 | -$11,990 | -$9,957 |
| Capital Expenditures | -$190 | -$2,693 | -$3,327 | -$962 |
| Free Cash Flow | -$12,175 | -$14,851 | -$15,317 | -$10,919 |